Cargando…

Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals

People living with HIV (PLWH) require life-long anti-retroviral treatment and often present with comorbidities such as metabolic syndrome (MetS). Systematic lipidomic characterization and its association with the metabolism are currently missing. We included 100 PLWH with MetS and 100 without MetS f...

Descripción completa

Detalles Bibliográficos
Autores principales: Olund Villumsen, Sofie, Benfeitas, Rui, Knudsen, Andreas Dehlbæk, Gelpi, Marco, Høgh, Julie, Thomsen, Magda Teresa, Murray, Daniel, Ullum, Henrik, Neogi, Ujjwal, Nielsen, Susanne Dam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791652/
https://www.ncbi.nlm.nih.gov/pubmed/35095835
http://dx.doi.org/10.3389/fimmu.2021.742736
_version_ 1784640230025854976
author Olund Villumsen, Sofie
Benfeitas, Rui
Knudsen, Andreas Dehlbæk
Gelpi, Marco
Høgh, Julie
Thomsen, Magda Teresa
Murray, Daniel
Ullum, Henrik
Neogi, Ujjwal
Nielsen, Susanne Dam
author_facet Olund Villumsen, Sofie
Benfeitas, Rui
Knudsen, Andreas Dehlbæk
Gelpi, Marco
Høgh, Julie
Thomsen, Magda Teresa
Murray, Daniel
Ullum, Henrik
Neogi, Ujjwal
Nielsen, Susanne Dam
author_sort Olund Villumsen, Sofie
collection PubMed
description People living with HIV (PLWH) require life-long anti-retroviral treatment and often present with comorbidities such as metabolic syndrome (MetS). Systematic lipidomic characterization and its association with the metabolism are currently missing. We included 100 PLWH with MetS and 100 without MetS from the Copenhagen Comorbidity in HIV Infection (COCOMO) cohort to examine whether and how lipidome profiles are associated with MetS in PLWH. We combined several standard biostatistical, machine learning, and network analysis techniques to investigate the lipidome systematically and comprehensively and its association with clinical parameters. Additionally, we generated weighted lipid-metabolite networks to understand the relationship between lipidomic profiles with those metabolites associated with MetS in PLWH. The lipidomic dataset consisted of 917 lipid species including 602 glycerolipids, 228 glycerophospholipids, 61 sphingolipids, and 26 steroids. With a consensus approach using four different statistical and machine learning methods, we observed 13 differentially abundant lipids between PLWH without MetS and PLWH with MetS, which mainly belongs to diacylglyceride (DAG, n = 2) and triacylglyceride (TAG, n = 11). The comprehensive network integration of the lipidomics and metabolomics data suggested interactions between specific glycerolipids’ structural composition patterns and key metabolites involved in glutamate metabolism. Further integration of the clinical data with metabolomics and lipidomics resulted in the association of visceral adipose tissue (VAT) and exposure to earlier generations of antiretroviral therapy (ART). Our integrative omics data indicated disruption of glutamate and fatty acid metabolism, suggesting their involvement in the pathogenesis of PLWH with MetS. Alterations in the lipid homeostasis and glutaminolysis need clinical interventions to prevent accelerated aging in PLWH with MetS.
format Online
Article
Text
id pubmed-8791652
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87916522022-01-27 Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals Olund Villumsen, Sofie Benfeitas, Rui Knudsen, Andreas Dehlbæk Gelpi, Marco Høgh, Julie Thomsen, Magda Teresa Murray, Daniel Ullum, Henrik Neogi, Ujjwal Nielsen, Susanne Dam Front Immunol Immunology People living with HIV (PLWH) require life-long anti-retroviral treatment and often present with comorbidities such as metabolic syndrome (MetS). Systematic lipidomic characterization and its association with the metabolism are currently missing. We included 100 PLWH with MetS and 100 without MetS from the Copenhagen Comorbidity in HIV Infection (COCOMO) cohort to examine whether and how lipidome profiles are associated with MetS in PLWH. We combined several standard biostatistical, machine learning, and network analysis techniques to investigate the lipidome systematically and comprehensively and its association with clinical parameters. Additionally, we generated weighted lipid-metabolite networks to understand the relationship between lipidomic profiles with those metabolites associated with MetS in PLWH. The lipidomic dataset consisted of 917 lipid species including 602 glycerolipids, 228 glycerophospholipids, 61 sphingolipids, and 26 steroids. With a consensus approach using four different statistical and machine learning methods, we observed 13 differentially abundant lipids between PLWH without MetS and PLWH with MetS, which mainly belongs to diacylglyceride (DAG, n = 2) and triacylglyceride (TAG, n = 11). The comprehensive network integration of the lipidomics and metabolomics data suggested interactions between specific glycerolipids’ structural composition patterns and key metabolites involved in glutamate metabolism. Further integration of the clinical data with metabolomics and lipidomics resulted in the association of visceral adipose tissue (VAT) and exposure to earlier generations of antiretroviral therapy (ART). Our integrative omics data indicated disruption of glutamate and fatty acid metabolism, suggesting their involvement in the pathogenesis of PLWH with MetS. Alterations in the lipid homeostasis and glutaminolysis need clinical interventions to prevent accelerated aging in PLWH with MetS. Frontiers Media S.A. 2022-01-12 /pmc/articles/PMC8791652/ /pubmed/35095835 http://dx.doi.org/10.3389/fimmu.2021.742736 Text en Copyright © 2022 Olund Villumsen, Benfeitas, Knudsen, Gelpi, Høgh, Thomsen, Murray, Ullum, Neogi and Nielsen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Olund Villumsen, Sofie
Benfeitas, Rui
Knudsen, Andreas Dehlbæk
Gelpi, Marco
Høgh, Julie
Thomsen, Magda Teresa
Murray, Daniel
Ullum, Henrik
Neogi, Ujjwal
Nielsen, Susanne Dam
Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals
title Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals
title_full Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals
title_fullStr Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals
title_full_unstemmed Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals
title_short Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals
title_sort integrative lipidomics and metabolomics for system-level understanding of the metabolic syndrome in long-term treated hiv-infected individuals
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791652/
https://www.ncbi.nlm.nih.gov/pubmed/35095835
http://dx.doi.org/10.3389/fimmu.2021.742736
work_keys_str_mv AT olundvillumsensofie integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT benfeitasrui integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT knudsenandreasdehlbæk integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT gelpimarco integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT høghjulie integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT thomsenmagdateresa integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT murraydaniel integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT ullumhenrik integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT neogiujjwal integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals
AT nielsensusannedam integrativelipidomicsandmetabolomicsforsystemlevelunderstandingofthemetabolicsyndromeinlongtermtreatedhivinfectedindividuals